For this study, we performed germline sequencing through a multigene panel that included established and candidate predisposition genes, in a cohort of Italian CM patients deemed at high-risk according to recent established criteria [8], but negative for CDKN2A/ARF and CDK4 pathogenic variants. The gene discussed is CDKN2A; the disease is cutaneous mastocytosis.